Compound Profile: Humalog
Humalog 100IU is a rapid-acting insulin analogue manufactured by Eli Lilly, specifically supplied for laboratory research applications investigating diabetes mellitus, metabolic pathways, and glucose homeostasis mechanisms. This insulin lispro formulation represents a biosynthetic human insulin analogue where the amino acids lysine and proline at positions B28 and B29 have been reversed, creating a modified absorption profile suitable for controlled experimental studies. Research teams at Stroid UK Shop utilise this pharmaceutical-grade compound to examine insulin signalling cascades, glucose uptake mechanisms, and cellular metabolic responses in laboratory settings.
Laboratory Applications
Researchers examine Humalog’s unique pharmacokinetic properties in studies investigating rapid insulin action, onset timing, and duration of effect in experimental models. The cartridge delivery system provides precise dosing capabilities essential for metabolic research protocols examining insulin sensitivity, glucose tolerance, and pancreatic beta-cell function. Scientists studying diabetes pathophysiology utilise this compound alongside other research materials from our general health insulin collection to investigate comparative insulin responses and therapeutic mechanisms. Laboratory investigations often incorporate this insulin analogue with complementary research compounds including selective androgen receptor modulators and research peptides to examine metabolic interactions and cellular signalling pathways.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Insulin Lispro |
| Concentration | 100 IU/mL |
| Form | Cartridge (3mL) |
| Manufacturer | Eli Lilly |
| Storage Requirements | 2-8°C (refrigerated) |
| Molecular Formula | C₂₅₇H₃₈₃N₆₅O₇₇S₆ |
| Molecular Weight | 5,808 Da |
| Product Code | EU11269 |
Research Compliance
This insulin analogue is supplied exclusively for legitimate scientific research, analytical testing, and laboratory investigations. Humalog 100IU cartridges are intended solely for qualified research institutions, academic laboratories, and licensed researchers conducting approved studies into diabetes mechanisms, insulin pharmacology, and metabolic pathway analysis. This product is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate storage conditions, follow institutional protocols, and ensure compliance with relevant research guidelines when handling this pharmaceutical-grade insulin analogue.
